Report

Medicines in Development for Mental Illnesses - 2012 Report

Medicines in Development for Mental Illnesses

PhRMA July 13, 2012

America’s biopharmaceutical research companies are developing 187 medicines to help the nearly 60 million American adults now suffering from some form of mental illness—from anxiety to depression and from schizophrenia to addictive disorders, such as dependence on alcohol or drugs. All of the medicines are either in clinical trials or awaiting review by the Food and Drug Administration.

Download